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Mapping the Energy of Antigen Recognition
by the induction of T cell activity. These studies have
illustrated the critical role of virtually all of the a and b
chain CDRs in pMHC recognition. However, this ap-
proach cannot elucidate either specific contacts that
are made with the peptide versus the MHC or the TCR/
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mutants. Moreover, structural analysis alone is unable§Scaggs Institute for Chemical Biology
to map the energy of antigen recognition, since buriedThe Scripps Research Institute
surface area correlates poorly with the energetic impor-La Jolla, California 92037
tance of individual residues (Cunningham and Wells,
1989; Dall'Acqua et al., 1996). The combined approach
of structural study and mutagenesis can provide insightSummary
at the molecular level into the processes of T cell selec-
tion, MHC restriction, and T cell function in general.The T cell receptor (TCR) from the alloreactive T lym-
Mariuzza and colleagues established that the struc-phocyte 2C recognizes a nonamer peptide QL9 com-
tures of a b chain (Bentley et al., 1995) and a Va homodi-plexed with the MHC class I molecule H2-Ld. Forty-
mer (Fields et al., 1995) resembled immunoglobulins (Ig).two single-site alanine substitutions of the 2C TCR
These structures also confirmed the existence of CDRwere analyzed for binding to QL9/Ld and anti-TCR anti-
loops, including HV4 inVa and Vb. More recent crystallo-bodies. The results provided a detailed energy map of
graphic studies of intact TCRs have shed light on theT cell antigen recognition and indicated that the pMHC
topology of the interaction between the T cell antigenand clonotypic antibody epitopes on the TCR were
receptor and pMHC (Garboczi et al., 1996; Garcia et al.,similar. Although residues in each Va and Vb CDR
1996a). Crystal structures of two MHC class I±restrictedare important in binding pMHC, the most significant
TCRs suggested that the receptor interacts with pMHCenergy for theTCR/QL9/Ld interaction was contributed
through a conserved, diagonal orientation. The fine speci-by CDRs 1 and 2 of both a and b chains. The extent
ficity necessary todistinguish conformations of differentto which the individual energy contributions are di-
peptides can be accounted for by direct contact of CDRrected at class I helices or peptide was also assessed.
residues with the pMHC ligand. All 2C a and b CDRs
are positioned such that they contact either peptide orIntroduction
MHC or, in some cases, both (Garcia et al., 1996a),
whereas in the A6 TCR, only four of the six CDRs have
A T cell recognizes foreign antigen as a peptide bound
significant contact with the pMHC complex (Garboczi
to a class I or class II product of the major histocompati-
et al., 1996).
bility complex (MHC). The specificity of this recognition
To understand the binding energies associated with
is determined by a heterodimeric ab cell surface protein
these contact residues, we have performed alanine scan-
called the T cell receptor (TCR). Like antibody genes,
ning mutagenesis of the 2C TCR, whose three-dimen-
TCR genes are formed by rearrangementprocesses that
sional structure in unliganded and liganded states has
generate a large repertoire of receptors with diversity recently been determined (Garcia et al., 1996a, 1998).
in loops that constitute the three complementarity-
In the past, single-site alanine scanning mutagenesis
determining regions (CDRs) (Davis and Bjorkman, 1988).
has been useful for constructing energy maps of numer-
The a and b chains also each contain an additional
ous protein interactions and for quantitating contribu-
hypervariable region, designated HV4. The molecular tions of individual residues tobinding. Notable examples
details of the interactions between TCR and peptide include the interaction of human growth hormone and
MHC (pMHC) ligands have been the focus of consider- its receptor (Cunningham and Wells, 1989; Clarkson and
able effort over the past 10 years (Eisen et al., 1996). Wells, 1995) and the interactions of antibodies with their
A number of studies have used mutagenesis to deter- antigens (Jin and Wells, 1994; Dall'Acqua et al., 1996).
mine the involvement of the variable (V) regions, CDRs, The 2C TCR is derived from the murine T cell clone
or individual residues in recognition by T cells (Hong et 2C (Kranz et al., 1984a), which recognizes an alloanti-
al., 1992; Kasibhatla et al., 1993; Patten et al., 1993; genÐan octamer peptide p2C or the nonamer version
Sant'Angelo et al., 1996). In each of these reports, muta- QL9Ðin complex with Ld (Udaka et al., 1992; Sykulev et
genized TCR genes were transfected into recipient T al., 1994). This TCR also recognizes two different pep-
cells, and the T cell transfectants were analyzed for their tide/Kb complexes: a self peptide, dEV8, bound to Kb
ability to recognize a specific pMHC ligand as measured (Tallquist et al., 1996) and a synthetic peptide, SIYRY-
YGL, bound to Kb (Udaka et al., 1996). The 2C TCR also
recognizes dEV8 bound to the negatively selecting class‖ These authors contributed equally to this study.
I moleculeKbm3 (Tallquistet al., 1996). Accordingly,analy-# To whom correspondence should be addressed (d-kranz@uiuc.
edu). ses of the binding energetics of a panel of 2C TCR
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Table 1. Single-Site Mutants Generated in the 2C scTCR (Va3.1/Vb8.2): Mutagenesis and Protein Expression for Residues in this Study
CDR1 CDR2 HV4 CDR3
24 25 26 27 28 29 30 31 48 49 50 51 52 53 54 55 67 68 69 70 71 72 73 93 99 100 101 102 103 104
Va3.1 Y S Y S A T P Y K Y Y S G D P V S K S N S S F S G F A S A L
Mutant * * * * * * * * * * * * * * * * * * * * * *
Expression defect * *
25 26 27 28 29 30 31 32 48 49 50 51 52 53 54 55 56 69 70 71 72 73 74 75 76 95 96 97 98 105 106 107
Vb8.2 Q T N N H N N M Y S Y G A G S T E R P S Q E N F S G G G G T L Y
Mutant * * * * * * * W * * * * * * * * * * * *
Expression defect * * * * * * *
Mutants are alanine mutants that could be expressed and refolded; expression defects are little or no protein yield, as judged by KJ16 and
F23.1 ELISAs, after small-scale colony screens or refolding of large-scale preparations.
alanine mutants with each of these ligands could reveal Results
details about the molecular basis of positive and nega-
TCR Mutagenesis and Purificationtive selection. Together with the three-dimensional struc-
The Vb8.2/Va3.1 TCR from cytotoxic T lymphocyte (CTL)tures, this information could allow assessment of the
clone 2C was produced as a single chain in an Esche-relative contributions of TCR contacts with peptide and
richia coli expression system to facilitate mutagenesisMHC residues.
studies (Soo Hoo et al., 1992; Schlueter et al., 1996b).We present here data from a quantitative alanine mu-
As shown previously, the solubility of this single-chaintagenesis scan of a TCR/ligand interaction. Residues
TCR (scTCR) was increased by expression as a C-termi-are identified in each Va and Vb CDR that are important
nal thioredoxin fusion protein (Schodin et al., 1996). Thefor binding of the QL9/Ld complex. In the recently deter-
scTCR was shown to retain the peptide/Ld specificity ofmined structure of the 2C TCR/dEV8/Kb complex, some
native TCR (Schlueter et al., 1996a, 1996b) and to reactof these residues were shown to contact the a1 or a2
with four antibodies that are specific for the 2C TCR:helices of Kb, while others contacted the peptide dEV8
F23.1 (Vb8.1±8.3), KJ16 (Vb8.1,8.2), F23.2 (Vb8.2), and(Garcia et al., 1998). The total binding contributions of
1B2 (clonotypic) (Haskinset al., 1984; Kranz et al., 1984b;Va residues were approximately equal to total binding
Staerz et al., 1985). The KJ16 and F23.1 antibodies rec-contributions of Vb residues. CDR1 and CDR2 residues
ognize overlapping epitopes on Vb8 that are locatedcollectively contributed more binding energy than CDR3
away from the pMHC binding site and that are distinctresidues. The binding energies associated with several
from the F23.2 and 1B2 epitopes. The F23.1 epitopeTCR side chains that contact conserved class I residues
includes residue 60bAsp (DiGiusto and Palmer, 1994),were also significant, consistent with the suggestion
and the KJ16 epitope includes residue 18bLys (Pullenthat TCRs have evolved inherent MHC reactivity that
et al., 1991; 16bLys by the nomenclature in their report).exists within germline-encoded portions of the TCR (Zer-
F23.2 and 1B2 have overlapping epitopes, since theserahn et al., 1997). Because recent evidence has shown
antibodies cross-compete with each other (our unpub-that a 3-fold difference in affinity can distinguish positive
lished data). However, F23.2 and 1B2 clearly have differ-or negative selection (Alam et al., 1996), these conserved
ent epitopes since F23.2 recognizes Vb8.2 chains paired
interactions could be important in thymic selection and/
with any Va (Behlke et al., 1987), whereas 1B2 is known
or the skewing of TCR repertoires toward class I versus
to recognize only the Va and Vb region combination
class II reactivity (i.e., CD8 vs. CD4 selection) (Sim et
derived from clone 2C (Soo Hoo et al., 1992). All four
al., 1996). In addition, they maybe important in establish-
antibodies recognize conformational epitopes on the 2C
ing the diagonal orientation of a TCR on the MHC prod-
TCR, since they require an intact intrachain disulfide
uct (Garboczi et al., 1996; Garcia et al., 1996a). bond within the TCR V domains for reactivity (Brodnicki
The 2C TCR also interacts, at higher affinity, with the et al., 1996). Based on these considerations, the anti-
anticlonotypic monoclonal antibody (mAb) 1B2 (Kranz bodies could be used collectively as probes for the gen-
et al., 1984b; Schodin and Kranz, 1993). We show that eral structural integrity of scTCR mutants and to assess
all of the TCR residues that contact the QL9/Ld ligand the concentration of properly folded mutants. In turn, the
also contact 1B2. However, two TCR residues in CDR2b panel of scTCR mutants could be used to resolve the
are important for 1B2 binding, but they have a negative epitopes of F23.2 and 1B2.
affect on QL9/Ld binding (i.e., the alanine mutants have Fifty of the 62 residues located within the six CDR
higher affinity for QL9/Ld). These contacts account, at and two HV4 regions of the 2C TCR were subjected to
least in part, for the greater affinity of the TCR/1B2 inter- alanine scanning mutagenesis (Table 1). 52bAla of the
action compared with the TCR/pMHC interaction. b chain CDR2 was changed to a tryptophan. Of the 51
Finally, the epitope of the Vb8.2-specific antibody single-site mutants, 42 were successfully expressed and
F23.2 (Staerz et al., 1985) includes residues in the CDR1 purified as scTCRs with acceptable levels of refolding
and CDR2 of the Vb domain, consistent with predictions (see below), yielding an overall success of 82% (summa-
from previous studies. The ability of this antibody to rized in Table 1), the same as that achieved for single-
distinguish between Vb8.2 and other members of the site mutants in other systems (Wells, 1991).
Vb8 subfamily (Vb8.1 and Vb8.3) could be accounted Refolding of scTCR proteins from inclusion bodies
generally resulted in 10%±25% monomeric, properlyfor by unique residues within these Vb8.2 CDRs.
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Figure 1. Antibody Reactivity of Representative scTCR Alanine Mutants
Wild-type or mutant scTCR preparations at various concentrations were used to inhibit the binding of biotinylated wild-type scTCR to the
Vb8-specific mAbs KJ16 (A), F23.1 (B), or F23.2 (C) in a competition ELISA. Bound biotinylated scTCR was detected by streptavidin-HRP.
Reactivity of scTCR mutants to the clonotypic mAb 1B2 (D) was assessed in a capture ELISA format involving immobilized 1B2 and employing
KJ16 as the detecting agent. The degree of reactivity of each mutant toward a specific antibody was determined as the IC50mut/IC50wt using
linear regression analysis. In 1B2 ELISAs, the concentration of TCR required for 50% maximal signal was used analogously to the IC50.
folded protein. The remaining protein existed as both grossly misfolded by these criteria (Table 1) and could
not be evaluated further. Not surprisingly, most of thesedisulfide-linked and noncovalently associated aggre-
gates. When tested for binding to 1B2, essentially all mutations were for residues suggested to be important
in overall stability of a CDR loop or individual Va or Vbthe active protein existed within monomeric fractions
(data not shown). Purification of scTCR mutants through domain, either through hydrogen bonding of side-chain
atoms (25bGln, 29bHis, 49bSer, 54bSer, and 69bArg) ora metal affinity chromatography column resulted in more
than 95% pure protein, with an apparent molecular through hydrophobic packing interactions within the V
domain (73aPhe, 32bMet, 69bArg, and 75bPhe) (Garciaweight by sodium dodecyl sulfate±polyacrylamide gel
electrophoresis (SDS-PAGE) of 42 kDa. Monomeric scTCR et al., 1996a).
A determination of each mutant's anti-Vb8 antibodycould be further isolated by HPLC G-200 size-exclusion
chromatography. Analysis of the CDR mutants by elec- reactivity was calculated as the half-maximal inhibitory
concentration for the mutant relative to that for the wildtrospray mass spectrometry confirmed both the purity
of preparations and the expected mass differences at- type (IC50mut/IC50wt) (averaged for KJ16, F23.1, and
F23.2). This value was used to normalize results of 1B2tributable to the single-site alanine mutations (data not
shown). The wild-type scTCR was observed as a single and QL9/Ld binding, in order to account for variations
in protein purity and fraction of properly folded material.peak with a mass of 40,536 6 3 Da (data not shown).
After normalization, similar binding results were ob-
tained for a mutant whether it was tested as a mono-TCR Folding and Vb8 Antibody Reactivity
To establish the extent to which the various mutant meric protein (i.e., metal affinity and HPLC G-200 puri-
fied) or as a mixture of monomeric and aggregate proteinpreparations exhibited proper refolding, we used the
Vb8-specific antibodies F23.1, KJ16, and F23.2 (a chain (i.e., metal affinity purified only) (data not shown).
mutants only) in a competition enzyme-linked immuno-
sorbent assay (ELISA). Vb8-specific antibodies were ad- TCR Binding to Anti-Vb8.2 Antibody F23.2
A previous study showed that a G53Db mutation elimi-sorbed to 96-well plates and then incubated with biotin-
ylated wild-type scTCR in the presence of mutant nated binding of a Vb8.2 region by antibody F23.2, sug-
gesting that the epitope of F23.2 includes CDR2 (PullenscTCRs. Basedon inhibition curves, the fraction of prop-
erly folded scTCR among different mutants was gener- et al., 1990; 51bGly mutation by the nomenclature in
their report). To resolve the epitope recognizedby F23.2,ally similar (Figure 1). Some mutants appeared to be
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Figure 2. Summary of scTCR Bindingto F23.2,
1B2, and QL9/Ld
Reactivities were calculated based on the rel-
ative IC50 of each mutant as compared to
the wild type using linear regression analysis.
Mutants that have decreased binding affinit-
ies compared to wild-type TCR are indicated
by bars extending above the zero line, while
mutants that have increased binding affinities
are indicated by bars extending below the
line. QL9/Ld assays were performed in tripli-
cate and ELISAs in duplicate. Error bars rep-
resent the standard deviation obtained from
two or more separate experiments. Mutants
for which QL9/Ld binding was not detectable
were considered as having at least 15-fold
reduced binding (i.e., 49aTyr, 50aTyr, 31bAsn,
48bTyr, and 50bTyr).
each TCR mutant was examined in a quantitative F23.2 four differences from Vb8.1 and nine differences from
Vb8.3 in these regions. Residues 28bAsn and 56bGluELISA (Figure 1C). None of the Va mutations affected
binding by F23.2, relative to reactivity with KJ16 and contribute the most energy to the F23.2/Vb8.2 interac-
tion, and both of these residues are different in Vb8.3.F23.1 (Figure 2). However, mutations in four residues
(28bAsn, 48bTyr, 50bTyr, and 56bGlu) of the Vb region Although Vb8.1 and Vb8.2 are identical at these posi-
tions, Vb8.1 has a nonconservative substitution (G→D)had a significant effect on F23.2 binding. In addition, the
nonconservative substitution of a tryptophan at 52bAla at residue 53. Since changes at residues 52bAla (this
report) or 53bGly (Pullen et al., 1990) affect F23.2 bind-also reduced the binding of F23.2 by approximately
5-fold, relative to that of KJ16 and F23.1 (data not ing, it is clear that the Vb8.1 substitution at residue 53
accounts in part for the ability of F23.2 to distinguishshown). Thus, the epitope for F23.2 encompasses both
the CDR1 and CDR2 loops of the b chain (Figures 2 and between the Vb8.1 and Vb8.2 regions.
3). The smaller, but still significant, effect of a mutation
at 72bGln of the HV4 may be explained either by a direct
TCR Binding to Clonotypic Antibody 1B2contribution to the F23.2 epitope or, alternatively, by the
The availability of the clonotypic antibody 1B2 providesrole this residue plays in stabilizing CDR1 (i.e., the side
an excellent opportunity to examine a ligand whose epi-chain of 72bGln hydrogen bonds to the main chain of
tope overlaps with QL9/Ld, yet that binds to the TCRresidue 28bAsn).
with considerably higher affinity (KD z1029 M) (SchodinThe identification of key Vb8.2 residues involved in
and Kranz, 1993). A capture ELISA was used becauseF23.2 binding provides a molecular explanation for the
biotinylation of wild-type scTCR affected its binding toability of F23.2 to distinguishVb8.2 from Vb8.1 and Vb8.3
1B2. The concentrations of scTCR required to yield 50%regions. Comparison of the CDR1, CDR2, and HV4 se-
quences among these proteins shows that Vb8.2 has maximal binding were calculated and used to compare
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Figure 3. Structural Analysis of the 2C TCR Antigen Binding Site
Highlighting CDR loops (A), F23.2 epitope (B), 1B2 epitope (C), and QL9/Ld epitope (D). Colors shown reflect the reactivities presented in
Figure 2, with red indicating residues that have the greatest influence on antigen binding, pink those with a moderate influence, yellow those
with a negligible influence, and green indicating a mutant with significantly improved binding. The 2C TCR surface depicted is from the 2C/
dEV8/Kb complex.
the reactivities of mutants with the wild type (Figures of scTCR binding in the T2-Ld cell assay, using various
QL9 peptide analogues, have been shown previously1D and 2).
Mutation of CDR2 tyrosines at positions 49a, 50a, 48b, (Schlueter et al., 1996a). Mutants were first character-
ized in a series of assays for their ability to inhibit Faband 50b all affected binding of 1B2. However, the great-
est effects were observed with mutations at 100aPhe binding at maximal scTCR concentrations (data not
shown). Mutants for which inhibition was undetectableand 31bAsn, both of which are highly solvent exposed
in the unliganded TCR structure. In fact, 100aPhe is the at maximal scTCR concentration were considered as
having at least 15-fold reduced binding. To quantitatemost prominent residueon the surface of the unliganded
TCR. Similar to results for F23.2, there was little ener- the relative affinities, titration binding studies were per-
formed with mutants that were capable of inhibiting Fabgetic contribution of HV4 residues in either the Va or
the Vb, with the possible exception of 72bGln in the HV4b binding (Figure 4). Two to six experiments were per-
formed for each mutant. From the titration of each mu-loop. As described above, this effect could either be
due to a direct contact with 1B2 or, perhaps more likely, tant, a QL9/Ld reactivity value was determined as the
IC50mut/IC50wt. This value was normalized for Vb8 reac-to destabilization of CDR1b. These data, together with
structural analysis, indicate that the 1B2 epitope covers tivity, and the average from separate experiments was
calculated (Figure 2).an area approximately 34 AÊ by 22 AÊ , centered over
CDR3b of the TCR. None of the four substitutions To confirm results of competition assays, several of
the a chain mutants were further analyzed using surface(102aSer, 55bThr, 56bGlu, and 76bSer) that resulted in
increased binding of QL9/Ld (see below) showed the plasmon resonance with purified QL9/Ld complexes. Di-
rect immobilization of scTCR yielded either no bindingsame effect with 1B2.
or variable results among the mutants, possibly attribut-
able to the reduced size and stability of the scTCR asTCR Binding to QL9/Ld
Alanine substitutions were assessed for their effect on compared to the full-length TCR. Therefore, a competi-
tion format was examined, using immobilized 2C TCRbinding of the TCR to QL9-Ld using a quantitative com-
petition assay involving the T2-Ld cell line. Selected mu- produced from Drosophila melanogaster cells (Garcia
et al., 1996b) and soluble QL9/Ld in the presence oftants were also examined by surface plasmon reso-
nance (BIAcore) analysis. The specificity and sensitivity soluble scTCR. The various mutant scTCRs tested as
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and 30aPro contributing intermediate energy. In CDR1
of the b chain, binding by the N31Ab mutant could not
be detected, while 27bAsn contributed intermediate
binding energy. The remaining CDR1b mutants that
could be folded properly exhibited activity similar to that
of the wild type.
The tyrosine residues at position 49 and 50 within
CDR2 of the a chain have been implicated in loop stabili-
zation (Garcia et al., 1996a) but are also accessible to
antigen. Mutation of either tyrosine to alanine eliminated
binding. The remaining CDR2a residues (51aSer, 53aAsp,
54aPro, and Val55a) that are more distal to the peptide-
binding site contributed negligible energy to binding.
These results indicate that the hydroxylmoiety of 51aSer
does not make a significant energetic contribution to
binding QL9/Ld. This discovery was surprising, because
this serine makes important contacts with Kb (Garcia et
al., 1998) and also has been implicated in skewing the
T cell repertoire toward the CD4 phenotype (Sim et al.,
1996). However, a proline at this position (found in the
Va3.2 region) was actually found to be more favored
than a serine in the preferential skewing toward a CD81
phenotype (Sim et al., 1996). Within CDR2b, 48bTyr and
50bTyr were similar to 49aTyr and 50aTyr in that alanine
substitution of either tyrosine residue abolished binding.
Residues 55bThr and 56bGlu in CDR2b were of interest
since alanine mutations at these positions resulted in a
2-fold increase in affinity. In the 2C/dEV8/Kb structure,
56bGlu lies 9 AÊ opposite 71Glu of the a1 helix, a nega-
tively charged residue common to both Kb and Ld that
may represent an unfavorable electrostatic interaction
surface.
Four CDR3 residues within the a chain were changed
to alanine. In the crystal structure of unliganded 2C,
residue 100aPhe plays a prominent role in guarding the
ªpocketº within the 2C binding site (Garcia et al., 1996a)
but occupies a completely different conformation in the
2C/dEV8/Kb complex (Garcia et al., 1998). The F100Aa
mutant exhibited a 4-fold reduction in binding. 93aSer
is accessible to antigen, yet an alanine substitution at
Figure 4. Inhibition of 125I Anti-Ld Fab Binding by Wild-Type and this position does not affect binding. In contrast, the
Representative Alanine Mutant scTCRs largely buried L104Aa mutant shows a significant bind-
T2-Ld cells that had been loaded with the peptide QL9 were incu- ing effect, perhaps attributable to disruptions in loop
bated for 1 hr at 48C with 125I Fab fragments and various concentra- stabilization. The alanine substitution at 102aSer im-
tions of inhibitor scTCR. Titrations were performed in triplicate, and
proved the affinity for QL9-Ld by 2-fold. In the crystalbound counts per minute were determined after spinning cells
structure, 102aSer lies directly over the center of thethrough oil to separate free 125I Fab fragments. QL9-Ld reactivity for
peptide but makes no ligand contacts. Modeling of theeach mutant was determined as the IC50mut/IC50wt. These values
were normalized for theextent of proper refolding, using Vb8 reactiv- 2C/QL9/Ld complex places 102aSer in a position of ste-
ity for each mutant. Representative resultsof several different exper- ric clash with P6Pro (Speir et al., 1998), thus providing
iments are illustrated. a possible basis for the increased affinity of this alanine
mutant. CDR3 of the b chain is unusually glycine rich,
and only one of these glycine residues (97bGly) was
inhibitors showed a similar order of reactivity as ob- changed to an alanine. The G97Ab, L106Ab, and Y107Ab
served in the Fab competition assay (D53 . S102 . mutants of CDR3b each exhibited a moderate (1.5- to
S69 5 wild type . F100 . T29 5 P30 5 Y26 5 K68). In 3-fold) reduction in binding to QL9-Ld. Therefore, al-
our experience, the T2-Ld cell binding assay was able to though these CDR3b residues make some contributions
resolve smaller differences in binding affinities, perhaps to binding, it does not appear that any is absolutely
because these assays can be performed at 48C and in critical for recognition. Mutation of 105bThr, which
the presence of bovine serum albumin (BSA), which makes no ligand contacts in the Kb complex, had no
might reduce nonspecific interactions. effect on binding QL9/Ld.
CDR1 of the a chain contributes a comparatively large Alaninesubstitutions of HV4 residues within both the a
binding energy to the 2C/QL9/Ld interaction, with 29aThr and b chains had minor or no effects on QL9/Ld binding.
Several mutations exhibited a reproducible 1.5- to 2-foldand 31aTyr being especially critical and 24aTyr, 26aTyr,
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Table 2. Comparison of 2C/dEV8/Kb Structural Contacts with 2C/QL9/Ld Binding Energetics of Alanine Substituent Mutants
Structural contact with dEV8/Kb
CDR TCR DDG:QL9/Ld
Loop Residue Peptide MHC Neither QL9/Ld Residues (kcal/mol 6 SD)
CDR1a Y24 X 0.98 6 0.10
S25 X 0.08 6 0.01
Y26 R62 R62 0.57 6 0.18
T29 X 2.05 6 0.23
P30 X 0.61 6 0.26
Y31 P1*/P2* R155 P1Gln, Y155 1.33 6 0.24
CDR2a Y49 X .1.48
Y50 R155 Y155 .1.48
S51 A158/G162/E166 A158/G162/E166 20.06
D53 X 20.01 6 0.11
P54 X 20.12 6 0.06
V55 X 0.12 6 0.09
HV4a S67 X 0.07 6 0.09
K68 X 0.20 6 0.05
S69 X 20.08 6 0.02
N70 X 20.06 6 0.09
S71 X 20.08 6 0.07
S72 X 0.24 6 0.09
P4Pro, P5Phe,
CDR3a S93 P4 P6Pro 20.15 6 0.03
F100 P4 Q65/R62 P4Pro, Q65/R62 0.76 6 0.12
S102 X 20.44 6 0.10
L104 X 1.42 6 0.05
CDR1b T26 Q149* Q149 0.15 6 0.05
N27 X 0.58
N28 K146/Q149 K146/Q149 0.25
N31 P6 P6Pro/P7Phe .1.48
CDR2b Y48 X .1.48
Y50 V76/S73/Q72 V76/W73/Q72 .1.48
T55 Q72 Q72 20.37 6 0.12
E56 Q72 Q72 20.32 6 0.20
HV4b P70 X 20.12
S71 X 0.05
Q72 X 0.22
E73 X 20.06
N74 X 0.18
S76 X 20.21 6 0.18
P6Pro/P7Phe,
CDR3b G97 P6 R155 Y155 0.40
T105 X 0.05
L106 X 0.43
Y107 X 0.58
Structural contacts of TCR residues with the dEV8/Kb ligand were from the crystal structure of the 2C/dEV8/Kb complex (Garcia et al., 1998).
Binding free energy changes were calculated from anti-Ld Fab inhibition experiments performed at 48C based on IC50 comparison to wild type.
Underlining indicates main-chain contacts only.
* Contact via bound water molecule.
reduction in affinity. As described above for F23.2 and from the refined 2C/dEV8/Kb complex (Table 2). The po-
1B2, the Q72Ab mutant bound QL9-Ld with 2-fold re- sitioning over the pMHC of residues evaluated for ligand
duced affinity compared to wild type. In addition, a binding is illustrated using the modeled 2C/QL9/Ld com-
small, but highly reproducible and significant, effect was plex in Figure 5 (Speir et al., 1998). Although almost all
observed for the K68Aa mutant. 72aSer also showed a of the residues that contact dEV8/Kb were observed to
small but significant effect that might be expected by exert detectable influences on QL9/Ld binding, several
its role in stabilizing the HV4a loop through a hydrogen residues that significantly reduce binding to QL9/Ld do
bond to 67aSer. not obviously contact dEV8/Kb. These include 24aTyr,
29aThr, 30aPro, 49aTyr, 104aLeu, 27bAsn, 48bTyr,
106bLeu, and 107bTyr (Figure 2). Structural analysisStructural Comparison with the
suggests that many of these residues may be exerting2C/dEV8/Kb Complex
their effects through stabilization or positioning of resi-The effect of alanine substitutions on QL9/Ld binding
was compared with the observed structural contacts dues (or entire loops) that actually do contact ligand.
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pMHC ligands with measurable affinity and also reacts
with many of the Vb8-specific bacterial superantigens.
Furthermore, the availability of mice transgenic for the
2C TCR allows the correlation of biochemically mea-
sured ligand±receptor affinities with their immunological
consequences, whether it is thymic selection, activation
of naive CTL precursors, or the triggering of primed
CTLs.
For the approach of alanine scanning mutagenesis,
the 2C TCR offers the distinct advantage of having the
highest binding affinity yet described for a TCR/pMHC
interaction (KD 5 z1027 M for QL9/Ld [Sykulev et al.,
1994]). By taking advantage of this affinity, it was possi-
ble to quantitate the reductions in affinity associated
with many of the single-site alanine mutations. These
same alanine mutations can also be used in the future
to examine the contributions of individual residues to
binding dEV8/Kb, SIYRYYGL/Kb, and Vb8-reactive su-
perantigens. The 2C TCR system is also useful because
several mAbs recognize its V regions, including the clo-
notypic antibody 1B2, which serves as a high-affinity
probe for the structure of recombinant TCR.
Peptide/MHC Binding by the 2C TCR
Residues from all six CDR loops are clearly involved in
the 2C TCR/QL9/Ld interaction. The greatest degree of
binding energy is contributed by the CDR1 and CDR2
loops of both chains, a moderate amount by the CDR3
loops, and a very small but quantifiable amount by the
HV4 loops. Within the a chain, CDR1 is clearly the source
of the most significant binding energy. While CDR2 ap-
pears to be less important, mutation of the CDR loop-
stabilizing tyrosines at positions 49a and 50a dramati-
cally decreases binding. A similar observation holds for
the b chain, where the critical positions are CDR1 resi-
Figure 5. Analysis of the Binding Energetics of TCR Residues in the due 31bAsn and the loop-stabilizing tyrosines at posi-
2C/QL9/Ld Modeled Complex
tions 48b and 50b. In both the a and b chains, the most
Residues evaluated for binding to QL9/Ld are colored according to
distal of the CDR2 residues (53aAsp, 54aPro, 55bThr,the magnitude of their effect on ligand binding: red, greater than
and 56bGlu) show either equivalent or slightly improved8-fold reduced; pink, 2- to 8-fold reduced; yellow, 0.7- to 2-fold
binding when mutated to alanine. In the refined 2C/reduced; and green, less than 0.7-fold reduced (i.e., higher affinity).
(A) Side view with the Ld a2 helix in the foreground. (B) Top view with dEV8/Kb structure (Garcia et al., 1998), these distal CDR2
the complex rotated approximately 908 toward the viewer, about an residues are located in the area where the loop bends
axis passing through peptide QL9. Energy calculations provide an away from the MHC a helices toward solvent, and thus
estimate that approximately 37% of the energy is attributable to
these residues may not be positioned to contact QL9/Ld.interactions with the peptide and approximately 63% to interactions
The unliganded 2C TCR structure showed that 100aPhewith the antigenic MHC helices.
of the CDR3a protrudes prominently from the surface,
close to a hydrophobic pocket between CDR3a and
CDR3b that is positioned at the center of the TCR. OurHowever, several of these residues (especially 29aThr,
106bLeu, and 107bTyr) do not obviously appear to be expectations based on these aspects of the unliganded
2C TCR structure were that 100aPhe would be an impor-involved in stabilization and thus may make unique con-
tacts with the QL9/Ld ligand. Using the 2C/dEV8/Kb tant residue in contacting the pMHC ligand. It was there-
fore a surprise that many non-CDR3 residues have morestructure as a guide for assigning whether a TCR residue
contacts peptide, MHC, or both, it is possible toapproxi- significant effects than 100aPhe, although this residue
does contribute significantly (DDG 5 0.76 kcal/mol). Thismate that 37% of the energy (2.6 kcal/mol) is directed
at binding peptide and 63% is directed toward the MHC stands in contrast to the major effect of this position in
contacting 1B2 (discussed below). This apparent dis-(4.4 kcal/mol).
crepancy is understood in light of the 2C/dEV8/Kb com-
plex structure, in which 100aPhe has moved 6 AÊ to aDiscussion
position contacting the MHC a1 helix at 65Gln/62Arg.
Thus, interactions of this phenylalanine with QL9/Ld mayThe 2C T cell system provides a useful model for the
study of various aspects of T cell structure and function. have entropic penalties associated with its movement
at the surface.The 2C TCR binds to both allogeneic and syngeneic
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A previous report using Va3.1 and Va3.2 TCR trans- (Garcia et al., 1998), but it does hydrogen bond with
the main-chain oxygen of Ans28b in the unliganded 2Cgenic mice showed that CDR1 and CDR2 residues from
the a chain can skew the T cell repertoire toward either structure (Garcia et al., 1996a). Thus, our mutagenesis
results suggest that the HV4b loop is involved indirectlyCD41 or CD81 cells, presumably by biasing an interac-
tion with either class I or class II molecules (Sim et al., rather than directly in pMHC recognition. In a recent
study, the 2C/QL9/Ld interaction was modeled on the1996). This finding is entirely consistent with the large
binding energy we observe attributable to CDR1a and 2C/dEV8/Kb refined structure, and HV4b residue 69bArg
was suggested to contribute significantly to ligand bind-CDR2a, which are structurally positioned to interact
largely with the MHC helices rather than the peptide. In ing by an electrostatic interaction with the negatively
charged P8Asp of peptide QL9 (Speir et al., 1998). Muta-fact, two key residues at CDR1 position 27 and CDR2
position 51 have been implicated in these selection ef- genesis of 69bArg in the current study was unable to
address this question, since neither alanine nor glutamicfects. Although we were unable to evaluate 27aSer, resi-
due 51aSer did not contribute significant energy to the acid substitutions yielded properly refolded protein. The
inability to refold these mutants is not entirely unex-QL9/Ld interaction. This finding must be interpreted in
view of the CD4/CD8selection biases described origi- pected, since 69bArg is largely buried between CDR
loops and contributes important hydrogen bonds thatnally (Sim et al., 1996). Va3.1 (present in the 2C TCR)
was shown to skew cells toward the CD41 phenotype, stabilize CDR1b and CDR2b.
Similarly, within HV4a, a small but highly reproduciblewhile Va3.2 (containing a proline at position 51) skewed
cells toward a CD81 phenotype. What then accounts binding effect is seen with the K68A (DDG 5 0.20 kcal/
mol) and S72A (DDG 5 0.24 kcal/mol) mutants. Residuefor the fact that Va3.11 2C T cells are invariably skewed
toward a CD8 phenotype (Sha et al., 1988; Manning et 68aLys of the A6 Tax-specific TCR hydrogen bonds to
166Glu in the class I molecule HLA-A2 (Garboczi et al.,al., 1997)? Within the 2C TCR (which is entirely class I
restricted), other interactions (besides 51aSer) with the 1996). 68aLys is conserved among most Va genes and
residue 166Glu is conserved among all class I, but notMHC helices are clearly sufficient to direct this particular
T cell along the CD8 selection pathway. For example, class II, molecules. Within the 2C TCR, 68aLys may be
contributing its energy through an electrostatic ratherfour residues within CDR1 and CDR2 of the a chain
(26aTyr, 29aThr, 31aTyr, and 50aTyr) together account than direct interaction, since it is too distant from Kb
residues to form distinct hydrogen bonds. Alternatively,for greater than 5 kcal/mol of binding energy, largely
(but not exclusively) through interactions with residues in the 2C/QL9/Ld complex, these two residues may be
close enough to interact directly. In any event, the smallthat are conserved across class I molecules. Further-
more, the CDR1 and CDR2 of the Vb8.2 region from the effect seen with the K68A mutation seems to argue for
a weaker electrostatic interaction, at best.2C TCR contributes significant energy to the interaction
with pMHC. Some of these contacts are clearly with
MHC residues and thus most likely contribute during
Contribution of TCR Residues That Contactthe positive selection of these T cells during develop-
MHC Helices, Peptide, or Bothment. This possibility is supported by our previous find-
The 2C TCR may be unusual compared to foreign pep-ings (Tjoa and Kranz, 1994) and others' findings (Con-
tide/self MHC-specific TCR in that it has been selectednolly, 1994) that Vb8regions are preferentially expressed
for alloreactivity. It hasbeen suggested that the absencein T cells reactive with the p2C/Ld complex.
of allo-MHC molecules in the thymus allows developingOf those mutants that could not be analyzed because
alloreactive T cells to escape negative selection, a pro-of problems in expression or folding of the recombinant
cess that might result in generally higher affinities forTCR, three of the residues (48aLys, 29bHis, and 54bSer)
alloreactive TCRs (Sykulev et al., 1994). In this regard,are positioned at the surface of theTCR and could possi-
the 2C TCR might be expected to have a larger energybly be involved in binding QL9/Ld. Two of these residues
contribution from residues that contact the a helices(48aLys and 29bHis) are in contact with the dEV8/Kb
of the allo-MHC molecule, compared to residues thatligand.
contact primarily the peptide. Perhaps in line with this
argument, the 2C TCR contains CDR3 loops that are
relatively short and that also lack charged residues forInvolvement of HV4 Loops
Because the HV4b loop represents a major site of se- direct ionic interactions. Using the refined structure of
the 2C/dEV8/Kb complex (Garcia et al., 1998), assign-quence variation compared to Ig V regions, there had
been some early expectation that it might be important ments were made as to whether each residue tested for
binding contacted primarily MHC helices, peptide, both,in pMHC recognition (Patten et al., 1984). However, it is
clear from our results that the mutated residues within or neither. Based on this approach, we estimated that
the energy attributable to residues contacting the Ldeither the HV4a or HV4b loops contribute in only a minor
way to the thermodynamic stability of the TCR/QL9/Ld helices is approximately 4.4 kcal/mol, whereas the en-
ergy attributable to QL9 peptide contact is approxi-complex. Among the HV4 Vb residues, 72bGln appears
to have the most significant effect on recognition of mately 2.6 kcal/mol (Table 2). Thus it appears that
slightly more than one third of the totalenergy is directedQL9/Ld (as well as F23.2 and 1B2). The negative effect
of alanine substitution is probably due to destabilization at the peptide and almost two thirds toward the MHC.
This estimate is based on the premise that QL9/Ldof the CDR1 and HV4 loops rather than direct contact
with the ligand. This conclusion is based on the observa- and dEV8/Kb will have the same distribution of TCR con-
tacts to peptide versus MHC. However, the fact thattion that 72bGln does not contact the dEV8/Kb ligand
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peptide QL9 is a nonamer while dEV8 is an octamer residues that contact the 1B2 antibody. The structure of
another scTCR (KB5-C20) interacting with its clonotypicand the existence of the ªhydrophobic ridgeº in the Ld
molecule (Balendiran et al., 1997) would likely result antibody Fab fragment (DeÂ sireÂ -1) has recently been re-
ported (Housset et al., 1997). In that crystal structure,in greater solvent-exposed peptide area for QL9/Ld as
compared to dEV8/Kb. In the refined 2C/dEV8/Kb struc- the interaction was centered over the c9 strand of the
TCR Vb domain, a positioning similar to that reportedture, the proportional surface area of the pMHC con-
tacted by the TCR was 23% peptide and 77% MHC here for the 2C/1B2 interaction, which is centered
roughly over the CDR3b loop. An important differencehelices. Assuming that 2C interacts with both pMHC
complexes in a similar orientation, it is not unexpected is that only a limited number of TCR CDRs were involved
in the KB5-C20/DeÂ sireÂ -1 complex, whereas the 2C/1B2that the energy directed at peptide QL9 was greater
than this 23% surface area suggests. That is, the 3D interaction involves all six CDRs. Thus, consistent with
the exquisite specificity with which it recognizes 2C,structure of 2C/QL9/Ld may reveal that some of the inter-
actions assigned to MHC based on the2C/dEV8/Kb com- 1B2 contacts each of the areas of the TCR that might
be predicted to be the most antigenic (i.e., the CDRplex may actually be with the QL9 peptide. One such
key interaction has been proposed based on molecular loops).
Despite the overall similarity in contact residues formodeling of the complex (Speir et al., 1998).
The observation that a significant fraction of the bind- the QL9/Ld and 1B2 epitopes, important differences
were observed in relative energy contributions amonging energy is associated with contacts to conserved
residues of the MHC helices has important biological residues. Aside from the four critical tyrosines within
the CDR2 loops, the most important residues for 1B2implications. Considerable energetic contact occurs be-
tween CDR1 and CDR2 of the Va and Vb and the tops binding were 31bAsn 5 100aPhe . 28bAsn . 56bGlu,
whereas the most important residues for QL9/Ld bindingof the MHC a helices (Table 2 and Figure 5). We predict
that these contacts are responsible for the inherent MHC were 29aThr. 31aTyr 5 31bAsn . 100aPhe. In addition,
two Vb residues, 55bThr and 56bGlu, showed opposingreactivity that exists within germline-encoded portions
of the TCR (Zerrahn et al., 1997). Moreover, these inter- effects with the 1B2 and QL9/Ld ligands. Binding of 1B2
was reduced considerably by substitution of either ofactions are also likely to account for the affinity that
class I±restricted TCRs appear to have for nonrestricted these residues with an alanine, whereas binding of QL9/Ld
was increased slightly by the same substitution.MHC class I molecules and that has been predicted to
be a requirement for T cell survival in the periphery
(Tanchot et al., 1997).
F23.2 Epitope
Previous studies have shown that CDR1 and CDR2 of
the Vb8.2 region are important in binding by mAb F23.2.Similarities in TCR Contacts with Anticlonotypic
Antibody 1B2 and pMHC The fact that these CDRs are also involved in binding
by 1B2 accounts for the ability of 1B2 and F23.2 to blockThe binding energies associated with individual CDRs,
and even specific residues, for the 2C ligands QL9/Ld reciprocally the binding of each other. It is also clear
that neither CDR3b residues nor any Va residues areand 1B2 were remarkably similar. It is thus clear why the
1B2 antibody requires the specific Va and Vb domains involved in direct interactions with F23.2. This finding is
consistent with early studies that demonstrated F23.2expressed only by clone 2C and why the reactivity of
1B2 has been shown to reflect directly the reactivity of bound to T cells that expressed a Vb8.2 region, regard-
less of the Vb8.2 CDR3 or the associated a chain.soluble TCR with the QL9/Ld ligand (Schlueter et al.,
1996b). The energy map of TCR binding to both the Within CDR1 and CDR2, residue 31bAsn was among
the most critical for binding to 1B2 and QL9/Ld, yet itpMHC ligand and the anticlonotypic antibody is similar
in some ways to the interaction of the antilysozyme does not contribute to binding by F23.2. In contrast,
residues 56bGlu of CDR2, and toa lesser degree 28bAsnantibody D1.3 with its antiidiotypic antibody E5.2 (Bra-
den et al., 1996; Dall'Acqua et al., 1996). For example, of CDR1, are among the most critical for binding F23.2
(and 1B2), but these residues do not contribute to bind-both the 2C/1B2 and 2C/QL9/Ld complexes appear to
be stabilized by the accumulation of many productive ing QL9/Ld. These findings demonstrate that each of
these ligand interactions exhibits differences in theinteractions covering the entire binding interface, as with
the D1.3/E5.2 complex (Dall'Acqua et al., 1996). This mechanisms by which binding to the TCR is achieved.
Of the b chain residues examined, 28bAsn (CDR1),contrasts with the energy of the D1.3/lysozyme interac-
tion, where only a few of residues within the binding site 48bTyr, 50bTyr, and 56bGlu (CDR2) had the most signifi-
cant effects on the binding by F23.2. Comparison of theaccount for most of the binding energy (Dall'Acqua et
al., 1996). Vb8.2 sequence with Vb8.1 and Vb8.3 shows that only
Vb8.3 differs at any of these positions (N28→S andThe similarity of the 1B2 and QL9/Ld epitopes is sur-
prising given the major differences observed between E56→Q). The combined effect of mutations at these two
residues is greater than three orders of magnitude inTCRs and antibodies. That is, TCRs are believed to con-
tact their pMHC ligands with a conserved orientation binding affinity, and thus these residues can account
for the lack of reactivity of F23.2 with Vb8.3. The majorwhereas antibodies recognize numerous diverse topolo-
gies. In addition, TCRs have considerably lower affinities differences between Vb8.2 and Vb8.1 reside at residues
30 (N→D), 31 (N→Y), 51 (G→V), and 53 (G→D). Mutantthan most antibodies. These properties might have led
to the prediction that there would be significant differ- N30Ab exhibited some problems in folding (z5-fold re-
duced KJ16 and F23.1 reactivity), but it as well as N31Abences between the residues that contact pMHC and the
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Vb8.3 regions. F23.2 (Staerz et al., 1985) is a mouse IgG1 mAb thatwas shown to have unimpaired reactivity with F23.2
is specific for the mouse Vb8.2 region. 1B2 is an anticlonotypic(Figure 2 and data not shown). Nevertheless, Vb8.1 sub-
mouse mAb that is specific for the ab TCR found on the T cell clonestitutions at these two positions are less conservative
2C (Kranz et al., 1984b). 30-5-7 (Ozato et al., 1980) is a mouse IgG2a
than alanine mutations and could effect binding. Substi- mAb that is specific for the a2 domain of H2-Ld. Antibodies were
tution of a tryptophan at 52bAla reduced binding of purified from either culture supernatants or ascites. Fab fragments
of 30-5-7 were produced by digestion with papain (Sigma, St. Louis,F23.2 by 5-fold (data not shown). This finding, together
MO) for 5 min at 378C followed by size-exclusion chromatographywith previous evidence of the importance of 53bGly (Pul-
through a Superdex G-200 column. Residual intact mAb or Fc re-len et al., 1990), suggests that the ability of F23.2 to
gions were removed by passage over a protein A agarose columndistinguish between Vb8.2 and Vb8.1 resides in part in
(Gibco±BRL, Gaithersburg, MD).
this segment of CDR2.
ELISAs
Conclusions Vb8-specific competition ELISAs were performed by adsorption of
KJ16, F23.1 or F23.2 to the wells of Immulon 2 ELISA plates (Dyna-The 2C TCR binds to its alloantigenic ligand, QL9/Ld,
tech Labs, Chantilly, VA). The wells were blocked with phosphate-through residues located in each of the CDR in the a
buffered saline, 0.25% BSA, and 0.05% Tween, and after washing,and b chains. The order of energies involved in binding
100 ml of mutant or wild-type TCR and 50 ml of biotinylated wild-
is approximately CDR1a. CDR1b . CDR2a 5 CDR2b . type TCR at a 1:1000±1:3000 dilution were added to the wells. After
CDR3a 5 CDR3b. These relative binding contributions 30 min, the wells were washed and binding was detected using
correlate reasonably well with the surface contact areas horseradish peroxidase (HRP)±streptavidin and tetramethylbenzi-
dine peroxidase substrate (Kirkegaard and Perry, Gaithersburg,calculated for each of these regions from the crystal
MD). Inhibition curves were plotted and the IC50 for each mutantstructure of the 2C/dEV8/Kb complex (Garcia et al.,
and wild type were calculated using linear regression analysis. For1998). The results suggest that the 2C TCR interacts with
1B2 capture ELISAs, 1B2 was adsorbed to the wells, and after
these two peptide/class I complexes, which represent washing, 50 ml of mutant or wild-type TCR was added to the wells.
positive and negative selecting ligands for 2C, with simi- Bound TCR was detected with KJ16 and goat anti-rat HRPconjugate
lar orientations and with similar contributions to binding. (Kirkegaard and Perry).
In contrast to some expectations, the majority of the
binding energy resided in non-CDR3 residues. This Peptide/MHC Binding Assays
A competition cell-binding assay was used to monitor binding ofmight be in part accounted for by the fact that 2C CDR3s
TCR to QL9/Ld complexes, as previously described (Schlueter et al.,are shorter and contain fewer bulky residues than many
1996a, 1996b). To form peptide/Ld complexes on the surfaces ofother TCRs. TCRs with longer CDR3s are likely to have
T2-Ld target cells, cells were incubated with approximately 10 mMadditional interactions that contribute to antigen bind- of the specific peptide for 3±5 hr. For the competitive binding assay,
ing, as observed with the longer CDR3s in the A6/Tax/ peptide±up-regulated cells (3 3 105/well) were incubated with 0.7
HLA-A2 complex (Garboczi et al., 1996). In this respect, nM 125I 30-5-7 Fab and various concentrations of scTCR for 1 hr on
ice in the presence of 0.7% BSA. After incubation, bound and freethe 2C TCR might be a model of binding energetics
ligands were separated by centrifugation through dibutyl phthalate/achieved more throughTCR interactionswith MHC, than
olive oil. All assays were done in triplicate.through interactions with peptide. Thus, the 2C TCR has
For the BIAcore assay, Drosophila-expressed 2C TCR was immo-
provided a framework for understanding processes that bilized using classic carbodiimide amine coupling chemistry (BIA-
focus on these interactions, such as positive selection, core) to a CM5 sensorchip (200±500 response units) at pH 5.2 in 10
T cell survival, memory responses, and alloreactivity. mM acetate (Garcia et al., 1996b). Measurements were carried out
at 258C in phosphate-buffered saline (no detergent added) with a
flow of 20 ml/min on a BIAcore 2000. Sensorgrams from controlExperimental Procedures
surfaces (OVA-2 TCR) were subtracted from sensorgrams generated
on the 2C surface. Soluble H2-Ld was purified as previously de-scTCR Mutagenesis
scribed (Garcia et al., 1996b) and complexed to QL9 or murineVarious alanine-substituted scTCRs were constructed using a poly-
cytomegalovirus peptides (5-fold molar excess of peptide) at roommerase chain reaction (PCR)±based technique (Landt et al., 1990).
temperature. Competition experiments were conducted by coinjec-In brief, a short mutagenic primer and a Va- or Vb-specific primer
tion of a fixed amount of Ld with increasing concentration of scTCR.were used in the first PCR step to generate a ªmegaprimer º which
was then isolated and used in a second PCR with the opposing Va-
or Vb-specific primer. All PCR reactions were carried out using Statistical Analysis of Binding Data
cloned Pfu DNA polymerase (Stratagene, La Jolla, CA). Following The percentage inhibition of T2-Ld binding was corrected for the
the second PCR, the KpnI±Bam HI±digested product was ligated binding of 125I 30-5-7 Fab fragments to Ld molecules that do not con-
into pUC-19M, transformed into DH5a or NM522 strains for se- tain the peptide of interest, as follows: % inhibition 5 (cpmQL9, no TCR 2
quencing, subcloned into the pTRXFus vector (Invitrogen, San cpmQL9, with TCR)/(cpmQL9, no TCR 2 cpmno peptide) 3 100. Inhibition curves
Diego, CA), and transformed into GI698 for expression. were constructed, and within each experiment a sample of wild-
type scTCR was included as an internal control. QL9/Ld reactivity
was calculated as the IC50mut/IC50wt and was normalized for Vb8scTCR Expression and Purification
reactivity to account for variations in the percentages of properlyProteins were expressed in E. coli as described previously (Schodin
folded proteins. Results from titration experiments were consistentet al., 1996) and purified from inclusion bodies by denaturing metal
with the degree of inhibition observed in single-point inhibition stud-affinity chromatography and G-200 size exclusion chromatography.
ies (our unpublished data).Protein purity was assessed by SDS-PAGE as well as by electro-
spray mass spectrometry for several of the mutants (performed at
the University of Illinois Mass Spectrometry Facility). Structural Analysis
Structural analysis was performed on an Indigo 2 work station (Sili-
con Graphics, Mountain View, CA) using the Quanta Software pack-mAbs
KJ16 (Haskins et al., 1984) is a rat IgG mAb that is specific for the age (Molecular Simulations, Burlington, MA). The refined structure
of the 2C/dEV8/Kb complex (Garcia et al., 1998) was used to assignmouse Vb8.1 and Vb8.2 regions. F23.1 (Staerz et al., 1985) is a
mouse IgG2a mAb that is specific for the mouse Vb8.1, Vb8.2, and pMHC contacts for those 2C residues tested by mutagenesis.
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